Showing posts with label Bananas. Show all posts
Showing posts with label Bananas. Show all posts

Tuesday

Bananas may help detect, cure skin cancer — study


PARIS, France — The black spots on old banana peels may unlock a faster, easier diagnosis of human skin cancer, boosting survival chances, scientists said Monday.

When bananas ripen, their skin is covered in small, round black spots caused by an enzyme known as tyrosinase.

The same enzyme is present in human skin, and in greater quantities in people suffering from melanoma — a potentially deadly form of skin cancer.


A team of scientists used this observed commonality to build a cancer scanner, which they then refined and tested at length on banana peels before moving on to human tissue.

First, researchers at the Laboratory of Physical and Analytical Electrochemistry in Switzerland concluded that the enzyme is a reliable marker of melanoma growth.

In the earliest stage 1 of cancer, the enzyme is not very apparent, becoming widespread and evenly distributed in stage 2, and unevenly distributed in stage 3 — by when the cancer has started spreading to other parts of the body.

The earlier the cancer is detected, the greater the chances of survival.

According to the American Cancer Society, people have a 10-year survival rate of 95 percent if the melanoma is detected in stage 1 — falling to 43 percent by mid-stage 3.

The team developed a scanner and tested it on banana peel spots — which are roughly the same size as melanoma spots on human skin.

“By working with fruit, we were able to develop and test a diagnostic method before trying it on human biopsies,” team leader Hubert Girault said in a statement.

The scanner has eight flexible microelectrodes, spaced like comb teeth, that pass over the skin to measure the quantity and distribution of tyrosinase.

“This system could obviate the need for invasive tests like biopsies,” the team said.

Girault believes the scanner could be used one day to destroy tumors, hopefully rendering biopsies and even chemotherapy unnecessary.

“Our initial laboratory tests showed us that our device could be used to destroy the cells,” he said.

The research was published in the German science journal Angewandte Chemie.

source: technology.inquirer.net

Chiquita and Fyffes merge to make world's biggest banana firm


DUBLIN - U.S. fruit firm Chiquita Brands and Irish rival Fyffes, Europe's largest distributor, have struck an all-stock merger deal to create the world's biggest banana supplier.

The global banana market is controlled by four multinationals, according to the United Nations: Chiquita , Fresh Del Monte, Hawaii-founded Dole Food Company and Fyffes. With this $526 million deal the new firm, ChiquitaFyffes, will grab about 14 percent market share and $4.6 billion in annual revenues.

"The first three (companies) on a global scale are not too far away from each other, whereas Fyffes was a good deal smaller. Now a firm number one has been created, there will be some impetus for further consolidation in the sector," said David Holohan, an analyst at Merrion Stockbrokers in Dublin.

Chiquita and Fyffes sell 180 million boxes of bananas a year between them, versus 117 million for Del Monte and 110 for Dole. Their merger is expected to generate operational pre-tax savings of at least $40 million by the end of 2016.

The deal will be subject to review by competition authorities but, Holahan added, is unlikely to prompt burdensome regulatory demands because the two companies operate mainly in separate North American and European markets.

"I don't think competition is too big an issue with it," he said. "If Europe did require disposals, I don't think it would be a problem."

ChiquitaFyffes will have a market value of $1.1 billion, with Chiquita shareholders owning about 50.7 percent of the combined company and Fyffes shareholders the remaining 49.3 percent, the companies said.

Fyffes shares leaped nearly 30 percent on Monday, bringing the shares, which had traded at about 10 times earnings prior to the announcement, roughly into line with its peers.

Chiquita shareholders will get one share of the new company for each share held. Fyffes investors will get 0.1567 of a share in the new group for each existing share, which values it at a premium of 38 percent over its Friday's closing price.

ChiquitaFyffes will be listed in New York, but domiciled in Ireland, bringing tax savings similar to U.S. drugmaker Perrigo's acquisition of Elan last year.

Goldman Sachs and Wells Fargo Securities, LLC acted as financial advisers for Chiquita and its board and Lazard for Fyffes. — Reuters

source: gmanetwork.com